This inventor holds 1 USPTO granted patent. Top assignee: Merck Patent Gmbh. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Bernd Went: Innovator in Thiazolylpiperidine Derivatives
Introduction
Bernd Went is a notable inventor based in Weil, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target metabolic disorders. His work has implications for the treatment of conditions such as hypertriglyceridaemia and hypercholesterolaemia.
Latest Patents
Bernd Went holds 1 patent for his invention titled "Thiazolylpiperidine derivatives as MTP inhibitors." This patent focuses on thiazolylpiperidine derivatives of the general formula (I). The application of these compounds is aimed at treating hypertriglyceridaemia, hypercholesterolaemia, and dyslipidaemia, showcasing their potential in addressing critical health issues.
Career Highlights
Bernd Went is associated with Merck Patent GmbH, where he has been instrumental in advancing research and development in pharmaceutical innovations. His expertise in medicinal chemistry has positioned him as a key player in the industry.
Collaborations
Throughout his career, Bernd has collaborated with esteemed colleagues such as Philippe Guèdat and Francois Collonges. These partnerships have fostered a collaborative environment that enhances the innovation process.
Conclusion
In summary, Bernd Went is a distinguished inventor whose work on thiazolylpiperidine derivatives has the potential to significantly impact the treatment of metabolic disorders. His contributions to Merck Patent GmbH and collaborations with other experts highlight his commitment to advancing pharmaceutical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile